SecBot

SecBot
Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001082554

UTHR

UNITED THERAPEUTICS Corp
$573.51 ▲ +0.37%
Prev close $571.38
Market cap$20.7B
ConsensusStrong Buy
12-mo target$644.36 (+12.6%)
▲ Bullish
Analyst conviction 8/10
Insider Selling Cluster (3 insiders)35 New Institutional Positions15 Institutional Exits Biotech & Drug Discovery
Snapshot
The big-picture read on UTHR right now — valuation, ownership and activity at a glance.
Market Cap
$20.7B
Cap Size
Large Cap
Analyst Consensus
Strong Buy (82%)
Inst. Holders
50 funds
Inst. Value
$17.2B
Inst. Activity
35 buys / 15 sells
Insider Activity
$0.00 buy / $10.8M sell
Insider Net $
-$10.8M
Social Sentiment
50° Neutral
SEC Reports
20
Price chart 30d +16.6%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 Insider
MAHON PAUL A sold 160 shares
EVP & GENERAL COUNSEL @ $573.15 ($91.7K)
Oct 1, 2026 Insider
MAHON PAUL A sold 823 shares
EVP & GENERAL COUNSEL @ $572.25 ($471.0K)
Oct 1, 2026 Insider
MAHON PAUL A sold 838 shares
EVP & GENERAL COUNSEL @ $570.90 ($478.4K)
Oct 1, 2026 short_volume
Short Volume: UTHR — 72.9% short (0.5M / 0.7M)
Short: 527,225 | Exempt: 89 | TRF Vol: 723,236 | Short Ratio: 72.9% | Off-exchange volume (dark pool
Sep 16, 2026 SEC
CEO Martine Rothblatt sold ~$1.37M in open-market shares on Sept 14, 2026, part of a larger cluster of option exercises
CLUSTER — Impact 2/10
Sep 12, 2026 SEC
CEO Martine Rothblatt sold ~$6.9M in open-market shares on Sep 9-10, 2026, while simultaneously exercising stock options
CLUSTER — Impact 3/10
Sep 11, 2026 SEC
CEO Martine Rothblatt sold ~$5.9M of UTHR stock over two days (Sep 8-9), including shares acquired via option exercises
CLUSTER — Impact 4/10
Jun 30, 2026 Inst.
WELLINGTON MANAGEMENT GROUP LLP — TRIM
1,379,025 shares ($747.2M)
Analyst ratings buy % +15.5%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Strong Buy 82% rate it Buy or better · 22 analysts
Strong Buy 6 27% Buy 12 55% Hold 4 18% Sell 0 0% Strong Sell 0 0%
Recent analyst actions
DateFirmActionRatingFirm rating
Oct 1, 2026BTIGUPGRADEBuy 53%
Sep 24, 2026Goldman SachsINITIATESell 54%
Aug 6, 2026RBC CapitalMAINTAINOutperform 55%
Jul 23, 2026JP MorganMAINTAINOverweight 55%
Jul 10, 2026B of A SecuritiesMAINTAINNeutral 54%
Jul 7, 2026RBC CapitalMAINTAINOutperform 55%
May 7, 2026RBC CapitalMAINTAINOutperform 55%
May 7, 2026Wells FargoUPGRADEOverweight 54%
Apr 10, 2026Morgan StanleyMAINTAINEqual-Weight 55%
Monthly consensus history
PeriodStr. BuyBuyHoldSellStr. SellBuy %Distribution
Sep 1, 202661240082%
Aug 1, 202661240082%
Jul 1, 202661240082%
Jun 1, 202661240082%
May 1, 202671050077%
Apr 1, 20267950076%
Mar 1, 20267950076%
Feb 1, 20267860071%
Price targets
Where 14 covering analysts think UTHR trades over the next 12 months.
$644.36 +12.6% upside Buy
Current$572.50 Low$321.00 Median$685.00 High$728.00 14 analysts
$321.00$728.00
Analyst rating Buy· 1.9/5 as of Oct 2, 2026
Social media sentiment mood +0.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
50°
Neutral
BearishNeutralBullish
2 mentions 0 bullish 0 bearish 2 neutral
Recent posts
investing Neutral 6mo ago
Market Close Report - Monday, March 30, 2026
▲ 1 · 💬 0· ⚡ 0.5
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
20 SEC filing reports analyzed · 0 bullish, 0 bearish, 3 mixed, 17 neutral · avg impact 2.8/10.
NEUTRALCLUSTER2/10
CEO Martine Rothblatt sold ~$1.37M in open-market shares on Sept 14, 2026, part of a larger cluster
Sep 16, 2026
NEUTRALCLUSTER3/10
CEO Martine Rothblatt sold ~$6.9M in open-market shares on Sep 9-10, 2026, while simultaneously exer
Sep 12, 2026
MIXEDCLUSTER4/10
CEO Martine Rothblatt sold ~$5.9M of UTHR stock over two days (Sep 8-9), including shares acquired v
Sep 11, 2026
NEUTRALCLUSTER3/10
CEO Martine Rothblatt sold ~$6.4M in open-market shares on the same day United Therapeutics announce
Sep 10, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Oct 1, 2026
short_volume
Short Volume: UTHR — 72.9% short (0.5M / 0.7M)
Short: 527,225 | Exempt: 89 | TRF Vol: 723,236 | Short Ratio: 72.9% | Off-exchange volume (dark pool + OTC)
Sep 30, 2026
short_volume
Short Volume: UTHR — 69.1% short (1.1M / 1.6M)
Short: 1,077,733 | Exempt: 3,522 | TRF Vol: 1,558,770 | Short Ratio: 69.1% | Off-exchange volume (dark pool + OTC)
Sep 15, 2026
short_interest_report
Short Interest: UTHR up 36% to 2.8M shares
Settlement 2026-09-15 | Days to cover: 3.90 | ≈6.53% of shares outstanding (est.)
Sep 7, 2026
dark_pool
Dark Pool: UTHR — 0.6M shares, 29,425 trades
Week starting 2026-09-07. Total ATS volume: 566,281 shares across 29,425 trades.
Aug 31, 2026
dark_pool
Dark Pool: UTHR — 0.8M shares, 34,260 trades
Week starting 2026-08-31. Total ATS volume: 777,149 shares across 34,260 trades.
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
PeriodEPS Est.RangeGrowth30d RevUp/DnRevenue#
Current Q$6.46$4.40–$7.63-9.8%+0.3%4↑ 7↓$0.8B13
Next Q$6.71$3.05–$8.35-12.8%+0.1%6↑ 6↓$0.8B13
Current FY$26.08$22.65–$29.05-6.4%+0.1%6↑ 7↓$3.1B14
Next FY$28.79$19.07–$36.1010.4%+0.3%2↑ 11↓$3.5B14
Current-quarter EPS estimate — revision history
WhenEPS estimateChange vs now
Current$6.461—
7d ago$6.459+0.002
30d ago$6.439+0.022
60d ago$7.000-0.539
90d ago$7.028-0.567
Institutional ownership
Which big funds own UTHR (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $17.2B total value (31,772,295 shares) as of 2026-Q2. Top holders: BlackRock,, Avoro, VANGUARD. Net buying activity: 35 institutions added/increased vs 15 reduced.
Top holders — 2026-Q2
FundSharesValue% TrackedLast move
BlackRock, Inc.5,294,529$2.9B16.7%—
Avoro Capital Advisors LLC2,777,777$1.5B8.7%—
VANGUARD PORTFOLIO MANAGEMENT LLC1,919,429$1.0B6.0%—
VANGUARD CAPITAL MANAGEMENT LLC1,918,256$1.0B6.0%—
STATE STREET CORP1,898,064$1.0B6.0%—
RENAISSANCE TECHNOLOGIES LLC1,708,739$925.8M5.4%—
WELLINGTON MANAGEMENT GROUP LLP1,379,025$747.2M4.3%TRIM -39.1%
GEODE CAPITAL MANAGEMENT, LLC996,598$538.9M3.1%—
Jupiter Topco LLC831,129$450.1M2.6%—
NORGES BANK694,753$376.4M2.2%NEW
Recent position changes
FundActionPrevCurrentChangeValue
WELLINGTON MANAGEMENT GROUP LLPTRIM2,264,2471,379,025-39.1%$747.2M
NORGES BANKNEW—694,753—$376.4M
MILLENNIUM MANAGEMENT LLCDOUBLED153,372409,074+166.7%$221.6M
JANE STREET GROUP, LLCDOUBLED2,759285,926+10263.4%$154.9M
Qube Research & Technologies LtdADD123,441233,639+89.3%$126.6M
AmundiADD147,599219,094+48.4%$118.7M
Point72 Asset Management, L.P.ADD149,303201,159+34.7%$109.0M
TD ASSET MANAGEMENT INCADD104,588168,649+61.3%$91.4M
GOLDMAN SACHS GROUP INCADD114,419165,979+45.1%$89.9M
Man Group plcADD77,495134,890+74.1%$73.1M
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
2 insiders, 50 transactions. Net -$10.8M — $0.00 bought, $10.8M sold.
DateInsiderTitleTypeSharesPriceValue
Oct 1, 2026MAHON PAUL AEVP & GENERAL COUNSELSELL160$573.15$91.7K
Oct 1, 2026MAHON PAUL AEVP & GENERAL COUNSELSELL823$572.25$471.0K
Oct 1, 2026MAHON PAUL AEVP & GENERAL COUNSELSELL838$570.90$478.4K
Oct 1, 2026MAHON PAUL AEVP & GENERAL COUNSELSELL739$569.15$420.6K
Oct 1, 2026MAHON PAUL AEVP & GENERAL COUNSELSELL720$567.76$408.8K
Oct 1, 2026MAHON PAUL AEVP & GENERAL COUNSELSELL400$566.41$226.6K
Oct 1, 2026MAHON PAUL AEVP & GENERAL COUNSELSELL1,480$563.09$833.4K
Oct 1, 2026MAHON PAUL AEVP & GENERAL COUNSELSELL780$561.87$438.3K
Oct 1, 2026MAHON PAUL AEVP & GENERAL COUNSELSELL1,480$560.19$829.1K
Oct 1, 2026MAHON PAUL AEVP & GENERAL COUNSELSELL880$558.30$491.3K
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for UTHR.
Shares short
2,800,470
Settlement Sep 15, 2026
Change vs prior
+36.0%
Semi-monthly cycle
Days to cover
3.9
At avg daily volume
Of shares outstanding
≈6.5%
Estimate — not % of float
All UTHR filing & press-release reports (91)